Resolution of praziquantel

scientific article

Resolution of praziquantel is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1371/JOURNAL.PNTD.0001260
P3181OpenCitations bibliographic resource ID519191
P932PMC publication ID3176743
P698PubMed publication ID21949890
P5875ResearchGate publication ID51665815

P50authorPiero OlliaroQ72250873
Michael WoelfleQ124657543
Matthew H. ToddQ29017168
P2093author name stringJean-Paul Seerden
Kees Pouwer
Jesse de Gooijer
P2860cites workOpen science is a research acceleratorQ21004179
Taste, a new incentive to switch to (R)-praziquantel in schistosomiasis treatmentQ21090121
Identification of oxadiazoles as new drug leads for the control of schistosomiasisQ24642230
SchistosomiasisQ28215200
Quantitative high-throughput screen identifies inhibitors of the Schistosoma mansoni redox cascadeQ28472122
Reduced susceptibility to praziquantel among naturally occurring Kenyan isolates of Schistosoma mansoniQ28475935
Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific.Q54199827
PraziquantelQ56656935
Comparison of the therapeutic efficacy and side effects of a single dose of levo-praziquantel with mixed isomer praziquantel in 278 cases of schistosomiasis japonicaQ68025820
Comparative in vitro and in vivo activity of racemic praziquantel and its levorotated isomer on Schistosoma mansoniQ69943322
Comparative efficacy of praziquantel and its optic isomers in experimental therapy of schistosomiasis japonica in rabbitsQ70336138
Praziquantel derivatives I: Modification of the aromatic ringQ80446307
The Family Approach to the Resolution of RacematesQ95526529
Mesenteric venous thrombosisQ95783577
Interactions d'enantiomeres en solution ; influence sur le pouvoir rotatoire : Purete optique et purete enantiomerique.Q114738731
Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasisQ29619819
Susceptibility to praziquantel of male and female cercariae of praziquantel-resistant and susceptible isolates of Schistosoma mansoniQ33504927
Towards an understanding of the mechanism of action of praziquantelQ33914691
The global status of schistosomiasis and its controlQ34510931
Resistance of Schistosoma mansoni to praziquantel: is there a problem?Q35021630
Drugs for the control of parasitic diseases: current status and development in schistosomiasisQ35569078
Chemotherapy of schistosomiasis: present and futureQ36891317
Praziquantel: mechanisms of action, resistance and new derivatives for schistosomiasisQ37315241
Process evaluation of schistosomiasis control in Uganda, 2003 to 2006: perceptions, attitudes and constraints of a national programmeQ38873931
Resisting control of neglected tropical diseases: dilemmas in the mass treatment of schistosomiasis and soil-transmitted helminths in north-west UgandaQ38877533
Africa is desperate for praziquantelQ39078359
Efficient multicomponent reaction synthesis of the schistosomiasis drug praziquantel.Q42906063
Praziquantel analogs with activity against juvenile Schistosoma mansoniQ43123274
In vitro responses of praziquantel-resistant and -susceptible Schistosoma mansoni to praziquantelQ43713527
A comparison of the antischistosomal effect of levo- and dextro-praziquantel on Schistosoma japonicum and S. mansoni in miceQ44619194
Highly enantioselective catalytic acyl-pictet-spengler reactionsQ45028813
P275copyright licenseCreative Commons Attribution 4.0 InternationalQ20007257
P6216copyright statuscopyrightedQ50423863
P433issue9
P407language of work or nameEnglishQ1860
P921main subjectpraziquantelQ424145
infectious diseaseQ18123741
P304page(s)e1260
P577publication date2011-09-01
P1433published inPLoS Neglected Tropical DiseasesQ3359737
P1476titleResolution of praziquantel
P478volume5

Reverse relations

cites work (P2860)
Q58864744A comparison of the palatability of racemic praziquantel and its two enantioseparated isomers in yellowtail kingfish Seriola lalandi (Valenciennes, 1833)
Q64947379A novel praziquantel solid lipid nanoparticle formulation shows enhanced bioavailability and antischistosomal efficacy against murine S. mansoni infection.
Q55222741Activation of host transient receptor potential (TRP) channels by praziquantel stereoisomers.
Q34057535Activity of praziquantel enantiomers and main metabolites against Schistosoma mansoni.
Q51551327Decades down the line: the viability of praziquantel for future schistosomiasis treatment.
Q33747366Design and synthesis of molecular probes for the determination of the target of the anthelmintic drug praziquantel
Q39535453Enhancing the usefulness of cross dehydrogenative coupling reactions with a removable protecting group
Q47178426Experiences with a researcher-centric ELN.
Q47158108Experiences with a researcher-centric ELN† †Electronic supplementary information (ESI) available. See DOI: 10.1039/c4sc02128b Click here for additional data file
Q28478606First Universities Allied for Essential Medicines (UAEM) Neglected Diseases and Innovation Symposium
Q28543846Inhibition or knockdown of ABC transporters enhances susceptibility of adult and juvenile schistosomes to Praziquantel
Q56054493MyExperimentalScience, extending the ‘workflow’
Q26883657Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles
Q21004179Open science is a research accelerator
Q28660808Open source drug discovery - a limited tutorial
Q21144491Open source drug discovery in practice: a case study
Q39164325Praziquantel for Schistosomiasis: Single-Drug Metabolism Revisited, Mode of Action, and Resistance.
Q26752354Schistosomiasis Prevalence and Intensity of Infection in Latin America and the Caribbean Countries, 1942-2014: A Systematic Review in the Context of a Regional Elimination Goal
Q48478678Schistosomiasis and its treatment
Q90709519Six Laws of Open Source Drug Discovery
Q40045557Slow-release praziquantel for dogs: presentation of a new formulation for echinococcosis control
Q46081944Synthesis and SAR studies of praziquantel derivatives with activity against Schistosoma japonicum.
Q28678693Ten simple rules for cultivating open science and collaborative R&D;
Q46247381The anthelmintic praziquantel is a human serotoninergic G-protein-coupled receptor ligand
Q36083496The cytotoxicity study of praziquantel enantiomers
Q28484503The outcome of the oxidations of unusual enediamide motifs is governed by the stabilities of the intermediate iminium ions
Q38495068Toward organometallic antischistosomal drug candidates
Q50881127Validated capillary electrophoretic method for the enantiomeric quality control of R-praziquantel.
Q39004186What is the mechanism of action of praziquantel and how might resistance strike?